CareDx Gross Margin 2013-2025 | CDNA

Current and historical gross margin for CareDx (CDNA) over the last 10 years. The current gross profit margin for CareDx as of March 31, 2025 is %.
CareDx Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.35B $0.23B 67.15%
2024-12-31 $0.33B $0.22B 66.77%
2024-09-30 $0.31B $0.21B 65.50%
2024-06-30 $0.30B $0.19B 64.98%
2024-03-31 $0.28B $0.17B 62.91%
2023-12-31 $0.28B $0.18B 63.57%
2023-09-30 $0.30B $0.19B 64.53%
2023-06-30 $0.31B $0.20B 64.61%
2023-03-31 $0.32B $0.21B 65.20%
2022-12-31 $0.32B $0.21B 65.42%
2022-09-30 $0.32B $0.21B 65.72%
2022-06-30 $0.32B $0.21B 66.35%
2022-03-31 $0.31B $0.21B 66.88%
2021-12-31 $0.30B $0.20B 67.23%
2021-09-30 $0.28B $0.19B 67.75%
2021-06-30 $0.25B $0.17B 68.38%
2021-03-31 $0.22B $0.15B 67.87%
2020-12-31 $0.19B $0.13B 67.71%
2020-09-30 $0.17B $0.11B 66.86%
2020-06-30 $0.15B $0.10B 65.33%
2020-03-31 $0.14B $0.09B 65.47%
2019-12-31 $0.13B $0.08B 63.78%
2019-09-30 $0.12B $0.07B 61.74%
2019-06-30 $0.10B $0.06B 59.80%
2019-03-31 $0.09B $0.05B 58.43%
2018-12-31 $0.08B $0.04B 57.14%
2018-09-30 $0.07B $0.04B 57.58%
2018-06-30 $0.06B $0.03B 57.89%
2018-03-31 $0.05B $0.03B 56.86%
2017-12-31 $0.05B $0.03B 55.10%
2017-09-30 $0.05B $0.02B 51.06%
2017-06-30 $0.05B $0.02B 51.06%
2017-03-31 $0.05B $0.02B 47.83%
2016-12-31 $0.04B $0.02B 48.78%
2016-09-30 $0.04B $0.02B 54.05%
2016-06-30 $0.03B $0.02B 56.25%
2016-03-31 $0.03B $0.02B 64.29%
2015-12-31 $0.03B $0.02B 67.86%
2015-09-30 $0.03B $0.02B 72.41%
2015-06-30 $0.03B $0.02B 72.41%
2015-03-31 $0.03B $0.02B 68.97%
2014-12-31 $0.03B $0.02B 67.86%
2014-09-30 $0.03B $0.02B 65.38%
2014-06-30 $0.03B $0.02B 60.00%
2014-03-31 $0.02B $0.01B 60.87%
2013-12-31 $0.02B $0.01B 59.09%
Sector Industry Market Cap Revenue
Medical Medical Services $1.129B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.821B 26.97
CVS Health (CVS) United States $84.326B 10.48
Elevance Health (ELV) United States $78.255B 10.10
Cencora (COR) United States $58.178B 20.24
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $22.086B 0.00
Labcorp Holdings (LH) United States $21.684B 17.59
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.804B 0.00
Solventum (SOLV) United States $12.836B 13.59
CochLear (CHEOY) Australia $12.824B 0.00
ICON (ICLR) Ireland $12.156B 11.30
Revvity (RVTY) United States $11.802B 20.31
Viatris (VTRS) United States $10.833B 3.72
Avantor (AVTR) United States $9.247B 13.44
Medpace Holdings (MEDP) United States $9.225B 24.50
HealthEquity (HQY) United States $8.646B 37.87
Sonic Healthcare (SKHHY) Australia $8.518B 0.00
Charles River Laboratories (CRL) United States $7.808B 15.30
Caris Life Sciences,�Inc (CAI) United States $6.930B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.971B 29.27
BrightSpring Health Services (BTSG) United States $3.760B 34.50
Sotera Health (SHC) United States $3.296B 18.73
Surgery Partners (SGRY) United States $2.870B 37.32
Alignment Healthcare (ALHC) United States $2.750B 0.00
GeneDx Holdings (WGS) United States $2.622B 100.97
Concentras Parent (CON) United States $2.619B 15.13
Organon (OGN) United States $2.576B 2.74
Progyny (PGNY) United States $2.038B 44.87
Ardent Health (ARDT) United States $1.981B 8.45
PACS (PACS) United States $1.957B 0.00
Premier (PINC) United States $1.778B 13.49
GoodRx Holdings (GDRX) United States $1.739B 34.79
Teladoc Health (TDOC) United States $1.553B 0.00
Establishment Labs Holdings (ESTA) $1.303B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.948B 0.00
QDM (QDMI) Hong Kong, SAR China $0.846B 0.00
AMN Healthcare Services Inc (AMN) United States $0.833B 7.80
Nutex Health (NUTX) United States $0.643B 9.73
Embecta (EMBC) United States $0.619B 4.17
InnovAge Holding (INNV) United States $0.571B 0.00
SBC Medicals (SBC) United States $0.546B 0.00
LifeMD (LFMD) United States $0.535B 0.00
Sonida Senior Living (SNDA) United States $0.484B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.62
So-Young (SY) China $0.440B 0.00
Omada Health (OMDA) $0.434B 0.00
Enhabit (EHAB) United States $0.368B 30.29
Performant Healthcare (PHLT) United States $0.335B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.330B 0.00
Beauty Health (SKIN) United States $0.263B 0.00
Oncology Institute (TOI) United States $0.216B 0.00
DocGo (DCGO) United States $0.159B 26.00
Pheton Holdings (PTHL) China $0.132B 0.00
Sera Prognostics (SERA) United States $0.100B 0.00
KindlyMD (NAKA) United States $0.074B 0.00
Basel Medical Group (BMGL) Singapore $0.067B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.060B 0.00
Biodesix (BDSX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.024B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00